Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: August 2008

Dutton Associates Featured Company: ImaRx Therapeutics, Inc. (IMRX)

ImaRx Therapeutics, Inc. is a biopharmaceutical company engaged in developing and commercializing therapies for vascular disorders in the United States. The company’s operations are focused in two main areas. First, the company generates revenue from the sale of urokinase, a … Continue reading

Posted in Small Cap News | Leave a comment

Micromet Inc. (MITI) Makes Solid Headway in Development of New BiTE Antibody Platform

In some markets, companies rate an investment a “buy” when it meets a generally accepted set of parameters. In a certain sense, this method of investing in a market reduces risk to a proven and generally accepted formula. Every now … Continue reading

Posted in Small Cap News | Leave a comment

Reliv International Inc. (RELV) Supplementing Diets

Reliv International Inc. (RELV), based in Chesterfield, Missouri, is a developer, manufacturer, and marketer of a proprietary line of nutritional supplements. With a current market capitalization of $78.42M, they are a NASDAQ-traded company. The company’s products address basic daily nutrition … Continue reading

Posted in Small Cap News | Leave a comment

Something’s Fishy (In a Good Way) with Omega Protein Corp. (OME)

Headquartered in Houston, Texas, Omega Protein Corporation (OME) is the largest manufacturer in the United States of heart-healthy fish oils containing omega-3 fatty acids. Trading on the New York Stock Exchange (NYSE), the company is part of the Processed and … Continue reading

Posted in Small Cap News | Leave a comment

Interactive Data Corporation (IDC) Launches PlusFeed Select for Real-Time Global Market Delivery

Interactive Data Corporation (IDC) is a provider of financial market data, analytics and related services to financial institutions, active traders and individual investors. The company businesses, four in total, supply real-time market data, time-sensitive pricing, evaluations and reference data for … Continue reading

Posted in Small Cap News | Leave a comment

IRIDEX Corporation (IRIX) Receives FDA 510(k) Clearance for IQ Laser Systems

IRIDEX Corporation (NASDAQ: IRIX), a worldwide leader in the development, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices, recently announced receipt of FDA 510(k) clearance for its suite of IRIDEX IQ Laser Systems, covering the IRIDEX … Continue reading

Posted in Small Cap News | Leave a comment

Shares of Ivivi Technologies, Inc. (IVVI) Drop after the Announcement of the Company’s First Quarter 2009 Financial Results

Ivivi Technologies, Inc. (NASDAQ: IVVI), a leader in non-invasive, electroceutical® therapy systems designed to target and enhance the body’s anti-inflammatory response, recently announced the company’s financial results for the first quarter of the 2009 fiscal year. Shares of Ivivi Technologies, … Continue reading

Posted in Small Cap News | Leave a comment

Ceradyne Inc. (CRDN) Announces Completion of Acquisition of SemEquip, Inc.

Ceradyne Inc. (CRDN) is a developer and manufacturer of advanced technical ceramic products and components for defense, industrial, automotive, nuclear, electronic and medical markets. The company, based in Costa Mesa, California, has operating divisions in the U.S., Canada and Europe. … Continue reading

Posted in Small Cap News | Leave a comment

3Com Corp. (COMS) Announces Availability of Global Security Intelligence Portal

3Com Corp. (Nasdaq: COMS) provides secure, converged voice and data networking solutions for various enterprises. Through its TippingPoint division, 3Com provides network-based intrusion prevention systems for application protection, infrastructure protection and performance protection. TippingPoint today announced its real-time, global security … Continue reading

Posted in Small Cap News | Leave a comment

Dyax Corp. (DYAX) Reports Statistically Significant Results in Trials to Fight Hereditary Angioedema

Dyax Corp. (Nasdaq: DYAX) is a clinical-stage drug company focused on the discovery, development and commercialization of biotherapeutics for oncology and inflammatory conditions. The company today announced positive topline results from its second phase-3, placebo-controlled trial, EDEMA4, for its lead … Continue reading

Posted in Small Cap News | Leave a comment